Previous experience and quality of life in patients with inflammatory bowel disease during relapse;Experiencia previa y calidad de vida en pacientes con enfermedad inflamatoria intestinal durante los brotes de actividad

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 7, 2003, Pages 476-479

  Casellas, Francesc ^b   Lopez Vivancos J ^a   Malagelada, J R ^b  

^a HOSPITAL GENERAL DE CATALUNYA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Crohn's disease; Disease repercussion; Inflammatory activity; Inflammatory bowel disease; Quality of life; Questionnaires of quality of life; Ulcerative colitis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; ENTERITIS; EXPERIENCE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIC TEST; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SCORING SYSTEM; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL ANALYSIS; ULCERATIVE COLITIS; WELLBEING;

EID: 0041856086     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Casellas F, López Vivancos J, Vergara M, Malagelada J-R. Impact of inflammatory bowel disease on health-related quality of life. Dig Diseases 1999; 17: 208-18.
2. Casellas F, López Vivancos J, Badia X, Vilaseca J, Malagelada J-R. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000; 95: 177-82.
3. Casellas F, López Vivancos J, Casado, A, Malagelada J-R. Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality Life Research 2002; 11: 775-81.
4. Casellas F, López Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001; 13: 567-72.
5. Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001; 96: 2915-20.
6. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: Analysis of changes in disease over years. Gastroenterology 1994; 107: 3-11.
7. Lapidus A, Bernell O, Göran H, Löfberg R. Clinical course of colorectal Crohn's disease: a 35 year follow-up study of 507 patients. Gastroenterology 1998; 114: 1151-60.
8. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. Br Med J 1989; 298: 82-6.
9. Harvey RF, Bradshaw JM. A simple index of Crohn' s disease activity. Lancet 1980; 1: 514.
10. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 15-9.
11. López Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada J-R. Validation of the Spanish version of the inflammatory bowel disease questionnaire in ulcerative colitis and Crohn's disease. Digestion 1999; 60: 274-80.
12. EuroQol Group. EuroQol - A new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208.
13. Badia X, Fernández E, et al. Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Public Health 1995; 5: 87-93.
14. König HH, Ulshöfer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, et al. Validation of the EiuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 1205-15.
15. Dupuy HJ. The psychological general well-being (PGWB) index. En: Wegner NK, Mattson ME, Fuberg CP, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq, 1984.
16. Badia X, Gutiérrez F, Wiklund I, Alonso J. Validity and reliability of the Spanish version of psychological general well-being index. Quality Life Res 1996; 5: 101-8.
17. Casado A, Prieto L, Alonso J. El tamaño del efecto de la diferencia entre dos medias: ¿estadísticamente significativo o clínicamente relevante? Med Clin 1999; 112: 584-8.
18. De Boer AG, Sprangers MA, Bartelsman J, de Haes JC. Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study. Eur J Gastroenterol Hepatol 1998; 10: 783-9.